August 13th, 2004, 06:38
|
|
Administrator
|
|
Join Date: 2001
Posts: 1,085
|
|
|
Depreotide chest SPECT demonstrates pulmonary metastases from renal cell carcinoma
This case report found that 99mTc-Depreotide was able to detect pulmonary metastases of a 78-y-old man with postradical nephrectomy for renal cell carcinoma. The authors note that (99m)Tc-depreotide chest SPECT can be used to diagnose secondary lung cancer, including pulmonary metastases from renal cell carcinoma with a somatostatin receptor-positive tumor. Depending on whether the (99m)Tc-depreotide was positive for pulmonary metastases, the patient underwent an appropriate therapy without further invasive procedures.
J Nucl Med Technol. 2004 Mar;32(1):19-21.
99mTc-Depreotide chest SPECT demonstrates pulmonary metastases from renal cell carcinoma.
Shih WJ, Romero RA, Timothy M, Milan PP.
Nuclear Medicine Service, VA Medical Center, Lexington, Kentucky, USA. wshih0@uky.edu |
Linear Mode
